(CALM) Cal-Maine Foods - Ratings and Ratios
Shell Eggs, Egg Products, Ready-to-Eat Eggs, Specialty Eggs, Conventional Eggs
Dividends
| Dividend Yield | 10.23% |
| Yield on Cost 5y | 29.21% |
| Yield CAGR 5y | 340.29% |
| Payout Consistency | 75.6% |
| Payout Ratio | 33.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 33.2% |
| Value at Risk 5%th | 50.8% |
| Relative Tail Risk | -6.98% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.02 |
| Alpha | -14.50 |
| CAGR/Max DD | 0.73 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.385 |
| Beta | 0.376 |
| Beta Downside | 0.057 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.16% |
| Mean DD | 11.53% |
| Median DD | 9.90% |
Description: CALM Cal-Maine Foods November 06, 2025
Cal-Maine Foods, Inc. (NASDAQ: CALM) is the largest U.S. producer and distributor of shell eggs and egg-based products, operating a vertically integrated business that covers production, grading, packaging, marketing, and nationwide distribution. Its portfolio includes conventional eggs under brands such as Egg-Land’s Best and Sunups, as well as specialty lines-cage-free, organic, free-range, pasture-raised, and nutritionally enhanced eggs-plus ready-to-eat items like hard-cooked eggs, egg wraps, protein pancakes, and crepes. The company serves grocery chains, club stores, independent supermarkets, food-service distributors, and direct consumers across most U.S. regions and Puerto Rico.
Key operational metrics (FY 2023) show revenue of roughly $1.2 billion, an adjusted EBITDA margin near 12 %, and a net egg production capacity of ~2 billion eggs annually. The business is highly sensitive to feed commodity prices-especially corn and soy-because feed accounts for ~70 % of total costs; recent feed cost inflation has pressured margins, though higher retail egg prices (driven by sustained demand for cage-free and organic products) have partially offset the impact. A sector-wide trend is the accelerating consumer shift toward premium, “better-for-you” eggs, which historically commands a 15-20 % price premium and supports margin expansion for producers with diversified specialty lines.
For a deeper dive into CALM’s valuation dynamics and scenario analysis, you may find ValueRay’s data suite useful for extending your research.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (1.27b TTM) > 0 and > 6% of Revenue (6% = 263.9m TTM) |
| FCFTA 0.38 (>2.0%) and ΔFCFTA 21.82pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 35.85% (prev 38.37%; Δ -2.52pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.43 (>3.0%) and CFO 1.39b > Net Income 1.27b (YES >=105%, WARN >=100%) |
| Net Debt (-251.9m) to EBITDA (1.78b) ratio: -0.14 <= 3.0 (WARN <= 3.5) |
| Current Ratio 6.84 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (48.4m) change vs 12m ago -1.04% (target <= -2.0% for YES) |
| Gross Margin 43.54% (prev 28.02%; Δ 15.52pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 157.5% (prev 111.0%; Δ 46.47pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5514 (EBITDA TTM 1.78b / Interest Expense TTM 305.0k) >= 6 (WARN >= 3) |
Altman Z'' 15.77
| (A) 0.49 = (Total Current Assets 1.85b - Total Current Liabilities 270.0m) / Total Assets 3.20b |
| (B) 0.84 = Retained Earnings (Balance) 2.70b / Total Assets 3.20b |
| warn (B) unusual magnitude: 0.84 — check mapping/units |
| (C) 0.60 = EBIT TTM 1.68b / Avg Total Assets 2.79b |
| (D) 5.46 = Book Value of Equity 2.70b / Total Liabilities 494.5m |
| Total Rating: 15.77 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 87.91
| 1. Piotroski 7.50pt |
| 2. FCF Yield 44.18% |
| 3. FCF Margin 27.68% |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda -0.14 |
| 6. ROIC - WACC (= 45.14)% |
| 7. RoE 52.43% |
| 8. Rev. Trend 69.76% |
| 9. EPS Trend 15.12% |
What is the price of CALM shares?
Over the past week, the price has changed by +1.67%, over one month by -4.35%, over three months by -24.41% and over the past year by -4.97%.
Is CALM a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CALM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 98 | 15.7% |
| Analysts Target Price | 98 | 15.7% |
| ValueRay Target Price | 128.8 | 52% |
CALM Fundamental Data Overview December 05, 2025
P/E Trailing = 3.1784
P/S = 0.9115
P/B = 1.504
P/EG = 0.75
Beta = 0.216
Revenue TTM = 4.40b USD
EBIT TTM = 1.68b USD
EBITDA TTM = 1.78b USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -251.9m USD (from netDebt column, last quarter)
Enterprise Value = 2.76b USD (4.01b + (null Debt) - CCE 1.25b)
Interest Coverage Ratio = 5514 (Ebit TTM 1.68b / Interest Expense TTM 305.0k)
FCF Yield = 44.18% (FCF TTM 1.22b / Enterprise Value 2.76b)
FCF Margin = 27.68% (FCF TTM 1.22b / Revenue TTM 4.40b)
Net Margin = 28.86% (Net Income TTM 1.27b / Revenue TTM 4.40b)
Gross Margin = 43.54% ((Revenue TTM 4.40b - Cost of Revenue TTM 2.48b) / Revenue TTM)
Gross Margin QoQ = 33.74% (prev 48.16%)
Tobins Q-Ratio = 0.86 (Enterprise Value 2.76b / Total Assets 3.20b)
Interest Expense / Debt = unknown (Interest Expense 150.0k / Debt none)
Taxrate = 24.37% (64.2m / 263.3m)
NOPAT = 1.27b (EBIT 1.68b * (1 - 24.37%))
Current Ratio = 6.84 (Total Current Assets 1.85b / Total Current Liabilities 270.0m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = -0.14 (Net Debt -251.9m / EBITDA 1.78b)
Debt / FCF = -0.21 (Net Debt -251.9m / FCF TTM 1.22b)
Total Stockholder Equity = 2.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 39.71% (Net Income 1.27b / Total Assets 3.20b)
RoE = 52.43% (Net Income TTM 1.27b / Total Stockholder Equity 2.42b)
RoCE = 57.47% (EBIT 1.68b / Capital Employed (Total Assets 3.20b - Current Liab 270.0m))
RoIC = 52.54% (NOPAT 1.27b / Invested Capital 2.42b)
WACC = 7.40% (E(4.01b)/V(4.01b) * Re(7.40%) + (debt-free company))
Discount Rate = 7.40% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.45%
[DCF Debug] Terminal Value 79.58% ; FCFE base≈886.1m ; Y1≈971.9m ; Y5≈1.24b
Fair Price DCF = 445.0 (DCF Value 21.58b / Shares Outstanding 48.5m; 5y FCF grow 11.06% → 3.0% )
EPS Correlation: 15.12 | EPS CAGR: -32.14% | SUE: -3.34 | # QB: 0
Revenue Correlation: 69.76 | Revenue CAGR: 26.53% | SUE: -0.28 | # QB: 0
EPS next Quarter (2026-02-28): EPS=2.58 | Chg30d=-1.740 | Revisions Net=-2 | Analysts=2
EPS current Year (2026-05-31): EPS=10.04 | Chg30d=-5.720 | Revisions Net=-2 | Growth EPS=-59.9% | Growth Revenue=-21.2%
EPS next Year (2027-05-31): EPS=5.67 | Chg30d=-1.655 | Revisions Net=-2 | Growth EPS=-43.6% | Growth Revenue=-10.0%
Additional Sources for CALM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle